Durahist D

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer

Dexchlorpheniramine/methscopolamine/pseudoephedrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Dexchlorpheniramine/methscopolamine/pseudoephedrine is only recommended for use during pregnancy when benefit outweighs risk.

There are no data on the excretion of dexchlorpheniramine/methscopolamine/pseudoephedrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer